EnzyTag Competitors and Similar CompaniesClear all
EnzyTag's competitors and similar companies include Redesign Science, AEON Biopharma, Belite Bio and Domain Therapeutics.
 EnzyTag EnzyTag is a company developing CEPS (chemoenzymatic peptide synthesis), a peptide synthesis technology. It offers an entry into economic manufacturing processes for both linear peptide drugs and antibody-drug conjugates. |  Redesign Science Redesign Science is a computational chemistry company specializing in small molecule drug discovery. |  AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. |  Belite Bio Belite Bio is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting eye diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 2017 | Founding Date 2012 | Founding Date 2018 | Founding Date 2001 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Nuth, NL HQ | Locations New York, US HQ | Locations Irvine, US HQ Newport Beach, US | Locations San Diego, US HQ | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA |
Employees | Employees 4 | Employees 7 | Employees 6 | Employees 12 | Employees 811% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 39.5 m | Valuation ($) 2.1 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($39.2m) (FY, 2025) | Net income ($77.6m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 2m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3.9m (almost 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 2m | Total funding raised $ 112.6m | Total funding raised N/A | Total funding raised $ 41.5m |
For sources of this data, please see the company profile
View Company Profiles
Redesign Science
HQ
New York, US
Employees
7
Redesign Science is a computational chemistry company specializing in small molecule drug discovery.
View companyAEON Biopharma
HQ
Irvine, US
Employees
6
AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.
View companyBelite Bio
HQ
San Diego, US
Employees
12
Belite Bio is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting eye diseases.
View company
Domain Therapeutics
HQ
Illkirch-Graffenstaden, FR
Employees
81↓ 1% decrease
Domain Therapeutics is a biopharmaceutical company.
View company